Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure.
Autorzy:
Ustun C; Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Ritz EM; Rush Bioinformatics and Biostatistics Core, Rush University, Chicago, IL, USA. Vestergaard H; Department of Hematology, Odense University Hospital, Odense, Denmark. Pullarkat S; Department of Pathology, University of California, Los Angeles, CA, USA. Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Ohgami R; Department of Pathology, Stanford University, Stanford, CA, USA. Baughn LB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Kim Y; Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA. Ku NK; Department of Pathology, University of California, Los Angeles, CA, USA. Czuchlewski D; Department of Pathology, University of New Mexico, Albuquerque, NM, USA. Boe Møller M; Department of Hematology, Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; Mastocytosis Center Odense University Hospital, Odense, Denmark. Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria. Mrózek K; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Horny HP; Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany. George TI; Department of Pathology, University of New Mexico, Albuquerque, NM, USA.; Department of Pathology, University of Utah, Salt Lake City, UT, USA. Kielsgaard Kristensen T; Department of Pathology, Odense University Hospital, Odense, Denmark.; Mastocytosis Center, Odense University Hospital, Odense, Denmark. Beck T; Rush Bioinformatics and Biostatistics Core, Rush University, Chicago, IL, USA. Nathan S; Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL, USA. Arana Yi C; Department of Pathology, University of New Mexico, Albuquerque, NM, USA. Yeung C; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington School of Medicine, Seattle, WA, USA. Pullarkat V; Division of Hematology and HCT, City of Hope, Duarte, CA, USA. Gotlib J; Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA, USA. Akin C; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, MI, USA. Kohlschmidt J; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Salhotra A; Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA. SomaL; University of Washington School of Medicine, Seattle, WA, USA. Chen D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Han SY; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Cho C; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Sperr W; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria. Broesby-Olsen S; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense, Denmark. Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. Hoermann G; Division of Medical and Chemical Laboratory Diagnostics - Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Bloomfield C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Nakamura R; Division of Hematology and HCT, City of Hope, Duarte, CA, USA. Joachim Deeg H; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington School of Medicine, Seattle, WA, USA. Litzow MR; Department of Internal Medicine and Division of Hematology, Mayo Clinic, Rochester, MN, USA. Borthakur G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Perales MA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria. Marcucci G; Division of Hematology and HCT, City of Hope, Duarte, CA, USA.
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).
Autorzy:
Ustun C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Morgan E; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts. Moodie EEM; Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada. Pullarkat S; Department of Pathology, University of California, Los Angeles, California. Yeung C; Fred Hutchinson Cancer Research Center, Seattle, Washington.; University of Washington School of Medicine, Seattle, Washington. Broesby-Olsen S; Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense, Denmark.; Mastocytosis Center Odense University Hospital, Odense, Denmark. Ohgami R; Department of Pathology, Stanford University, Stanford, California. Kim Y; Department of Pathology, City of Hope National Medical Center, Duarte, California. Sperr W; Division of Hematology & Hemostaseology, Ludwig Boltzmann Cluster Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. Vestergaard H; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Hematology, Odense University Hospital, Odense, Denmark. Chen D; Department of Pathology, Mayo Clinic, Rochester, Minnesota. Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Mrózek K; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Czuchlewski D; Department of Pathology, University of New Mexico, Albuquerque, New Mexico. Horny HP; Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany. George TI; Department of Pathology, University of New Mexico, Albuquerque, New Mexico.; Department of Pathology, University of Utah, Salt Lake City, Utah. Kristensen TK; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark. Ku NK; Department of Pathology, University of California, Los Angeles, California. Yi CA; Department of Pathology, University of New Mexico, Albuquerque, New Mexico. Møller MB; Mastocytosis Center Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark. Marcucci G; Division of Hematology and HCT, City of Hope, Duarte, California. Baughn L; Department of Pathology, Mayo Clinic, Rochester, Minnesota.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria. Hilberink JR; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Pullarkat V; Division of Hematology and HCT, City of Hope, Duarte, California. Shanley R; Biostatistics and Bioinformatics, University of Minnesota, Minneapolis, Minnesota. Kohlschmidt J; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Coulombe J; Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada. Salhotra A; Division of Hematology and HCT, City of Hope, Duarte, California. SomaL; Fred Hutchinson Cancer Research Center, Seattle, Washington.; University of Washington School of Medicine, Seattle, Washington. Cho C; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, New York. Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Akin C; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, Michigan. Gotlib J; Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, California. Hoermann G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Hornick J; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts. Nakamura R; Division of Hematology and HCT, City of Hope, Duarte, California. Deeg J; Fred Hutchinson Cancer Research Center, Seattle, Washington.; University of Washington School of Medicine, Seattle, Washington. Bloomfield CD; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Litzow MR; Department of Internal Medicine and Division of Hematology, Mayo Clinic, Rochester, Minnesota. Valent P; Division of Hematology & Hemostaseology, Ludwig Boltzmann Cluster Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, New York. Borthakur G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2018 Sep; Vol. 7 (9), pp. 4447-4455. Date of Electronic Publication: 2018 Aug 16.
Pharmacokinetics, disposition, and plasma concentrations of dimethyl sulfoxide (DMSO) in the horse following topical, oral, and intravenous administration.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
